CONCURRENT ADMINISTRATION OF BIPOLAR ANDROGEN THERAPY AND NIVOLUMAB IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (COMBAT-CRPC)...NEW AWARD

The Johns Hopkins University

Investigators